|
The Next Wave:
New Strategies and Responses to HIV/AIDS in India, China, Russia
Sujatha Rao
National AIDS Control Organization, India (NACO)
Asia Society, New York
May 30, 2006
Thank you, ambassador. Ladies and Gentlemen,
I am extremely honored to be here this morning, to be able to share
with you some of my experience with what work we are doing on
HIV/AIDS in India, which is a concern globally, largely because
after South Africa, we have the largest number of people infected with HIV/AIDS. In terms of proportion to population, 99-percent of
India's population is still uninfected. We have 0.9-percent of the
people infected with this terrible infection.
India's response has been very comprehensive and one needs to study
in from a historical perspective, in terms of how the first
infection was detected in 1986 and how India has been responding to
the infection. Phase I was largely from 1986 to 1999. It took us
almost a decade to really understand what HIV was about. We went
through the typical phase of denial. We did not understand its
relevance, we did not understand its importance, and we did not
understand its epidemiology.
During the first phase, '93 to '99, we spend much of our time and
resourced trying to look at access to safe blood. At that time, data
showed that 9-percent of the infection transmission was through
infected blood. We had to set our house in order and show that we
provided safe blood; so much of our attention went into modernizing
blood banks and trying to see that the access to safe and
uncontaminated blood was ensured.
We brought the infection down to about 1.5-percent; that's the
latest data, which is a pretty good record. We also had spent a lot
of time on trying to raise awareness, and that brought us to a lot
of challenges. India is a very traditional society, particularly
when it comes to talking about sex. It's the land of Kama Sutra, so
it's not that we don't know about sex. So it's foolish to say that
we don't know all about sex.
But the point is talking about it; these are just simply dos and
don'ts that are conventionally put on board on how children behave
in the families, how the families are structured around these
issues, what you say and what you don't say in schools. Even now,
when we go to schools and some of the places and tell them, "You
must tell about sex and sexual education." The parents react by
saying, "Don't tell our children all about those dirty things."
So this is the kind of response that we still get, but it's come a
long way, certainly it has come a long way. Those were the days when
we were battling with trying to understand how to raise awareness on
the infection and the way it was spreading.
In 1999, we went into phase II. In the first phase, we had
experimented and carried out, very successfully, some pilot projects
and the lessons learned were that infection was really concentrated
among the high-risk groups, namely commercial sex workers.
We found a very concerted policy plan, and this experiment was
carried out in Calcutta where a very high, 6,000 to 8,000 sex
workers lived in the brothel, one of the largest brothels after
Bombay. There the infection rates really came down because there was
universal acceptance of use of condoms. STD rates came down and
infection rates were contained.
As contrasted to Bombay, which again had a huge brothel in Bombay
itself, I think of over 80,000 sex workers. There almost 55-percent
of the commercial sex workers were infected. Anecdotally, now a
large number of them have died. They couldn't get access to this information and condom use was very low. Each sex worker tended to
have anywhere between 5 and 10 partners a day, so that's how the
infection was spreading in the country.
We said, "This needs to be looked at and this is an area where we
really need to focus our energies."
Phase II really got into a really comprehensive strategy to work
closely with these commercial sex workers, injectable drug users,
particularly in the Northeastern part of the country Manipur,
bordering the Myanmar and Burma, where a lot of drugs get imported
into the country. You'd find in the tiny state of Manipur, I'm told,
that at least 40,000 youngsters in the age group of 18 to 24
infected with HIV, largely because of injectable drug use. So it's a
huge social program, therefore IDU also became one of our important
areas of concern.
The third, which has recently come into our vocabulary, is men
having sex with men. I must confess that this was not really seen as
such a big problem until a mapping exercise was taken up of all the
commercial groups in 2002/2003, and we found that men having sex
with men is a very huge number of people in India. It is so
intertwined with the cultural practices that it's a very different
approach all together, so we really need to be addressing strategies
on how to access them with information.
So we focused a lot in this phase II on these three high-risk
groups, particularly the commercial sex workers. The coverage is
pretty good; almost 60-percent of them we've been able to access.
Condom use is almost 50-percent among them.
Infection rates of STDs have certainly come down. Now that we have a
mapping exercise, it's going to be possible to really to do a
saturation policy. A saturation policy is what we're going to be
launching.
Right now, we have over 1,300 NGOs working with these groups,
largely commercial sex workers in IDU. As I said, MSM is gaining
importance. We're trying to recognize this lifestyle, and we're
trying to develop capacity among the NGOs on how to address them and
how to access information. When we say information, it's not just
merely going and telling them about the condom, but telling them
about the infection, getting them access to services, getting them
access to services for treatment and condoms.
Also, in terms of getting access to getting their status tested
through VCTC, that's Integrated Counseling and Testing Centers. But
I must say that awareness among all these high-risk groups,
according to our surveys, is quite impressive at over 72-percent,
but behavior change is slow in coming. That's something that we need
to be working on.
As of today, the phase II has come to a closure where the officials
are trying to take stock of what we've achieved, what has been our
response, what do we do now, where do we stand? In October, we're
launching a phase III part of the project. Our stock-taking has
shown that we've come a long way. The epidemic has matured and so
has our response.
Today there are 5.2 million people infected according to the latest
survey, versus 5.1 million last year. If you look at the trend, we
have about 750 sentinel sites. I'm told that is the largest in the
world. At these sentinel sites we collect about 400 samples from
each that are anonymous and unlinked. These are then tested at a
national reference laboratory, so the quality is absolutely,
undoubtedly good. These sentinel sites have shown two or three
disturbing trends.
While the good news is that it hasn't really exponentially grown as
expected, I have a caveat that I'll come to later on that, it has
also shown a disturbing trend of feminization of the epidemic. We
have almost 38-percent of women infected, which is much, much more
than what it was a few years ago. It has gone into the rural areas.
About 57-percent of the infection is in the rural areas.
Previously, we had thought that HIV was a fairly urban phenomenon,
but now it is getting into the rural areas, the rural households.
This means it is really the rich populations, the migrant workers
and the truck drivers, who tend to come to chronic opportunities in
the cities and take back the infection to the wives.
If the epidemic is a little contained, it's possible that it's
because the wives are not, in turn, having several sexual
relationships; it's stopping at the home. But nevertheless, it's
creating a huge social problem in the highly infected areas of the
country of sub-epidemics within this epidemic.
In the highly infected areas, I hear very disturbing stories about
women and how the discrimination and stigma hurts them much, much
more. They are far more vulnerable than an HIV-infected man.
Families would sell their assets, their land, their goats or sheep,
whatever they had to provide medical treatment, for example, to the
man. But when it is his wife who is infected, or she is widowed, she
is often thrown out of the house or left without any security. I
hear, this is in pockets, stories about she has been forced to
prostitution just for her children and herself to subsist.
This has now provoked us to come up with a very strong law, which is
going to give extensive rights to children infected with HIV and the
women, and this draft law is almost ready. We are going to be
placing it on the table of the House in the monthly session of the
Parliament. I think that is going to be our major focus now to fight
stigma and discrimination and protect women and children. This is
the social out-fall of this epidemic, which is not very easily
understood or spoken of, but the feminization of the infection that
is causing me great concern and is something that we're certainly
going to be focusing on. The second is the young, 15- to 29-year-
olds, almost 35-percent of them belong to this age group.
In several pockets, sexual permissiveness has come again. Taboos and
inhibitions, as a whole, young people are getting more vulnerable to
this infection. We need to reach out to them quickly. We have a
strong school education program. We have a strong program that
reaches out to them in the universities, but it is the workplace and
it's those who are not attending a formal institution structure;
that's where our challenge lies. Among the young, the 15- to 29-year-
olds, HIV/AIDS is probably one of the highest causes of death. It's
the third of the fourth cause of death among this band of 15- to 29-
year-olds after accidents and other causes.
So what has been our strategy? India, if you really look globally,
India's strategy has really been one of the most comprehensive one.
I believe strongly that the strategy is sound; it is based on
evidence, epidemiology, and the way the epidemic is unfolding. It is
based on the reality that we see in India. The strategy really
consists of an uncompromising adherence to the policy of prevention.
We believe that preventing this disease is going to be the most
effective component, but certainly it cannot be that you only do
prevention. We are looking at the continuum of care, the care and
support where you provide treatment for opportunistic infections. We
provide treatment and access to other services and, finally,
treatment itself that is affordable. In the AIDS case, we provide
ART.
It is in this context that I would just like to run you through. The
prevention strategy is not only working among the high-risk groups,
it is raising of general awareness of people on HIV infection,
ensuring blood safety and ensuring access to STD services. The
prevention policy itself is whole package of basic healthcare and
basic services related to HIV. Also, those who are infected by TB
get access to treatment. As you know, we find that 50 to 60-percent
of our HIV-infected persons are succumbing to TB. We did a study and
we found that among them, they came to us so late that even after
being treated on DOTS, 58-percent of them died. So this whole co-
infection between TB and HIV is something that's getting a lot of
attention. We have about 11,000 microscoping centers where DOTS is
provided, and that's where we are now trying to train the lab
technicians to also do HIV rapid test and really and fully expand
access to rapid testing of the status of people who are infected
with HIV.
The final component, which is very critical in the prevention
strategy, was started two or three years ago and is gaining rapid
momentum and that is what we call ICTC, Integrated Counseling and
Testing Centers. This is where we have a trained counselor and a
trained lab technician. It is in these centers where we have done a
lot of advocacy. We are doing a lot of awareness and asking people
to voluntarily come forward and get themselves tested.
I'm not so sure about whether testing should be made mandatory or
not. The policy currently in India is that it has to be voluntarily.
The Civil Society is not willing to accept the concept of mandatory
testing. There are two states, one of them from where I come, and
the epidemic is the highest in my state, where the Chief Minister
has been making statements that he would like mandatory testing
before marriage.
He is responding to a social crisis in that state where young women
have gotten married to HIV-positive men and the men have died. They
have become widows and they don't know where to go. It's made a lot
of people say, "This man has cheated on us." There are instances
where the man knew that he was HIV-positive and yet go married.
In response to this kind of crisis, there is the stock of mandatory
testing, but I'm so sure whether that would be a very efficacious
way of going about this problem, largely for two reasons. One is
that just before you are getting married you may make it mandatory.
First of all, because of the Hindu marriages, we don't have the
concept of registration. How many of them would really come in for
registration is one issue.
The second is that the infected person could be going through a
window period and may not get detected. So what is the whole point
of making this a mandated requirement? The third is even if it were,
the Civil Society is very concerned that even if you did have
mandatory testing and it is found that one of them is positive, the
blame is likely to come on the woman and the marriage or the
engagement would be broken off saying, "She has HIV." So the
confidentiality of it all gets exposed and the woman is then
condemned forever as HIV positive. She can go to counseling or not,
but nobody will believe her.
So these are the kinds of apprehensions that go into this who
concept of making it mandatory. Therefore, we are vigorously
following this policy of expanding access very quickly, as fast as
we can, to ensure that people walk in and get themselves tested. The
response has been fantastic in the six states that we have set out
this policy in the last two years, more particularly in the last few
months; we've set up over 2,700 centers in these six states. We ran
a campaign for the ICTC in the last 15 months and we found a 40-
percent increase in people coming forward to take the test. That is
strongly indicative that with a strong demand generating policy in
place through the ICTC campaigns and by putting the supply position
in place, there will be people who want to come forward and get
themselves tested. It is very useful because we see the HIV-positivity rate in these ICTCs to be 7, 10 or 12-percent. So this is
helping us to identify, counsel and also reach out to the HIV-
infected in time.
The care and support is the second segment of the whole continuum of
care. Here we have largely NGOs who run hospices, if I may put it
that way. Largely because men and women, particularly the poor are
infected. Either they're too poor to spend money and get themselves
treated, or they are being thrown out of the house, whatever the
case may be. But it is these people that are provided with treatment
in the hospices by the NGOs. They give them food, given them love,
give them care and it's very, very popular. Right now, we have 85 of
them. In this case, we are trying to link them up to the [inaudible]
centers with medical treatment of much better quality than the NGOs
have been able to provide and expand to 500 or so within the next
year or two. This is found to be very popular because people are
able to go there whenever they fall sick, get better and get back to
work, then they come back again if they fall ill and are taken care of.
There are two others aspects that are important to the treatment.
The next part is the third part of the strategy's treatment. Two
years ago we started when we announced the public policy that we
would provide ART to our HIV patients; that was sometime in May 2004
and we launched the first AIDS centers. Today we have 52 centers.
Almost 30,000 people are getting free treatment. Another 10,000 to
20,000 are getting from the private sector on their own, largely
because they probably don't want to come to government centers for
HIV care, mainly because of stigma and fear of recognition and
probably they can afford to buy their own drugs.
Our estimate is that about 50,000 people in India are accessing
antiretroviral treatment. At present, right now, we have done the
training, we have the equipment, we've purchased the drugs, in a
month's time we should be expanding and opening another 46 centers,
taking the total number to 100 centers. We should be able to provide
feasible access to ART to 100,000 people.
The challenge is in identifying these people and ensuring that they
know their risk status, and that they're able to take advantage of
the availability of the service and come forward. I am quite sure
that that's not a big problem because, informally, I am told already
that almost 65,000 people have registered in the centers for
treatment. I am sure that I will be able to reach my target of
100,000 which, under the Global Fund Project, was put as end of 2007
or 2008. I think in a couple of months we should be able to reach
the target. This shows a huge demand for ART treatment and brings
alongside testing and counseling facilities. As people get to know
their risk status, they are coming forward to the government centers
and taking care and treatment from us.
What is really of concern, again, is that recently, in the last
couple of months, we've got the Indian Association of Pediatrics to
come up with a treatment protocol for children. We only have 1,300
children on treatment. Epidemiologically, the estimations show that
we should be having at least 30,000 to 40,000 of them. But we have
only 1,300, so that's a huge gap and we are aware of the gap. We now
have the treatment protocols done. In June, we are going to be
talking to the pharmaceutical industry and trying to get them to
manufacture the drugs and the medicine in children's dosages. Once
that's done, about 10,000 children will able to get access. The Clinton Foundation has generously come forward to help us procure
these drugs. They are cheap by your standards, but by our standards
they are quite expensive for pediatric drugs.
I know in the US it is nothing much, but in terms of the Indian
Rupee, it's a lot. Therefore, I want to make mention of the Clinton
Foundation's generous offer. We are very grateful to them. The
Global Fund is also another source, but this was so ready that we
got plans done and the next day they said, "We are willing to help
you." So I should be able to roll this out. Once the response picks
up, we should be ready for 30,000 because now the protocols are
done. We are also developing about 7 to 10 premier institutions for
allied health and developing the capacity among pediatricians and
the other staff. You need the critical equipment for the
backstopping of this whole activity.
Finally, the mother-to-child transmission should, of course, come
under the prevention, but since it is so involved with drugs, I tend
to keep it under treatment. That's another area of great focus where
we need to do a lot more. Mother-to-child transmission; here again,
we've changed our protocols and the treatment regimen. We were on a
particular treatment which is very, very, very inexpensive, but now
we have taken much more of the combination drug regimen. So that
[inaudible] again a whole capacity building in terms of training, in
terms of logistics, in terms of ensuring drug adherence, and in
terms of reaching out to the mothers.
Finally, what is of great inspiration to me, I would say while in
this program, is that there is a huge network of the PLHAs that
we've been able to form. Increasingly and rapidly, we are able to
get the people living with AIDS to work in the program with us. They
work with us as outreach workers and we want to formalize their
involvement right from top to bottom in all levels of our work. I
feel that they bring in a lot of compassion, a lot of feeling, a
human face to the whole program, and inspire their other colleagues
along also.
To the Civil Society and the GPA strategies, I think we have a huge
number of partners with whom we are working. Finally, the challenge
will be in trying to come up with a comprehensive that will keep a
fine balance between prevention, support, and treatment because all three are critical and we just simply cannot give up any one of
those components. So that is the challenge. Thank you very much for
this opportunity. I am grateful to you for inviting me here.
|
|